Our tumor-derived human extracellular matrix (hECM) is specifically developed to replicate the complex biochemical and structural environment of the tumor microenvironment. Isolated from human oncological tissues through a proprietary gentle decellularization process, this ECM retains critical matrix proteins and signaling molecules that influence cancer cell behavior, including proliferation, invasion, and drug resistance. Ideal for advanced cancer research, drug screening, and tumor modeling, this hECM supports physiologically relevant 3D culture systems and promotes the formation of functional tumor-like structures. Available in a ready-to-use hydrogel format, it enables researchers to closely mimic in vivo conditions and gain more predictive insights into therapeutic responses.